Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu

被引:6
|
作者
Taleo F. [1 ]
Taleo G. [1 ]
Graves P.M. [2 ]
Wood P. [2 ]
Kim S.H. [3 ,4 ]
Ozaki M. [3 ]
Joseph H. [5 ]
Chu B. [6 ]
Pavluck A. [6 ]
Yajima A. [7 ]
Melrose W. [2 ]
Ichimori K. [2 ,8 ,9 ]
Capuano C. [3 ]
机构
[1] Government of Vanuatu, Vector Borne Disease Control Unit, Port Vila
[2] James Cook University, College of Public Health, Medical and Veterinary Sciences, Cairns and Townsville, QLD
[3] WHO Office of the Representative for the South Pacific and Division of Pacific Technical Support, Suva
[4] Liverpool School of Tropical Medicine, Liverpool
[5] The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC
[6] NTD Support Centre at the Task Force for Global Health, Atlanta, GA
[7] WHO Western Pacific Regional Office, Manila
[8] WHO Headquarters, Geneva
[9] Nagasaki University, Nagasaki
关键词
Vanuatu; Mass Drug Administration; Transmission Assessment Survey; Diethylcarbamazine Citrate (DEC); Antigen Prevalence;
D O I
10.1186/s41182-017-0057-6
中图分类号
学科分类号
摘要
Background: Vanuatu was formerly highly endemic for lymphatic filariasis (LF), caused by Wuchereria bancrofti and transmitted by Anopheles mosquitoes. After a baseline survey showing 4.8% antigen prevalence in 1998, the country conducted nationwide (in one implementation unit) annual mass drug administration (MDA) with albendazole and diethylcarbamazine citrate from 2000 to 2004 and achieved prevalence of 0.2% by 2006 in a representative nationwide cluster survey among all age groups. Methods: Post MDA surveillance was conducted from 2006 to 2012. After MDA, the country was divided for surveillance into three evaluation units (EUs) formed by grouping provinces according to baseline prevalence: EU1: Torba, Sanma and Malampa; EU2: Penama; EU3: Shefa and Tafea. The study compiled all past data and information on surveys in Vanuatu from the country programme. This paper reviews the surveillance activities done after stopping MDA to validate the interruption of transmission and elimination of LF as a public health problem. Results: Post-MDA surveillance consisting of at least three transmission assessment surveys (TAS) in each of the three EUs was conducted between 2006 and 2012. Sentinel and spot check surveys identified a few villages with persistent high prevalence; all antigen positive cases in these sites were treated and additional targeted MDA conducted for 3 years in 13 villages in one area of concern. All three EUs passed all TAS in 2007, 2010 and 2012 respectively, with no positives found except in EU2 (Penama province) in 2012 when 2 children tested positive for circulating filariasis antigen. Assessment of the burden of chronic filariasis morbidity found 95 cases in 2003 and 32 remaining cases in 2007, all aged over 60 years. Conclusions: Vanuatu has achieved validation of elimination of LF as a public health problem. Post-validation surveillance is still recommended especially in formerly highly endemic areas. © 2017 The Author(s).
引用
收藏
相关论文
共 50 条
  • [1] Elimination of lymphatic filariasis as a public health problem
    Cox, FEG
    [J]. PARASITOLOGY TODAY, 2000, 16 (04): : 135 - 135
  • [2] Elimination of lymphatic filariasis as a public health problem in Malawi
    Chiphwanya, John
    Mkwanda, Square
    Kabuluzi, Storn
    Mzilahowa, Themba
    Ngwira, Bagrey
    Matipula, Dorothy E.
    Chaponda, Limbikani
    Ndhlova, Paul
    Katchika, Prince
    Mahebere Chirambo, Chawananga
    Moses, Philemon
    Kumala, Justin
    Chiumia, Martin
    Barrett, Carrie
    Betts, Hannah
    Fahy, Joan
    Rebollo Polo, Maria
    Reimer, Lisa
    Stanton, Michelle C.
    Thomas, Brent
    Freer, Sian
    Molyneux, David H.
    Bockarie, Moses J.
    Mackenzie, Charles D.
    Taylor, Mark J.
    Martindale, Sarah
    Kelly-Hope, Louise A.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (02):
  • [3] National Mass Drug Administration Costs for Lymphatic Filariasis Elimination
    Goldman, Ann S.
    Guisinger, Victoria H.
    Aikins, Moses
    Amarillo, Maria Lourdes E.
    Belizario, Vicente Y.
    Garshong, Bertha
    Gyapong, John
    Kabali, Conrad
    Kamal, Hussein A.
    Kanjilal, Sanjat
    Kyelem, Dominique
    Lizardo, Jefrey
    Malecela, Mwele
    Mubyazi, Godfrey
    Nitiema, P. Abdoulaye
    Ramzy, Reda M. R.
    Streit, Thomas G.
    Wallace, Aaron
    Brady, Molly A.
    Rheingans, Richard
    Ottesen, Eric A.
    Haddix, Anne C.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2007, 1 (01):
  • [4] Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
    Ojha, Chet Raj
    Joshi, Basant
    Prakash, Khagendra K. C.
    Dumre, Shyam Prakash
    Yogi, Keshav Kumar
    Bhatta, Bandana
    Adhikari, Tulasi
    Crowley, Kathryn
    Marasini, Babu Ram
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (07):
  • [5] Mass drug administration for elimination of lymphatic filariasis: a discussion reply
    Karmakar, Prasanta Ray
    [J]. JOURNAL OF VECTOR BORNE DISEASES, 2011, 48 (03) : 182 - 182
  • [6] Elimination of lymphatic filariasis: current perspectives on mass drug administration
    Gyapong, John O.
    Owusu, Irene O.
    Vroom, Frances B. da-Costa
    Mensah, Ernest O.
    Gyapong, Margaret
    [J]. RESEARCH AND REPORTS IN TROPICAL MEDICINE, 2018, 9 : 25 - 33
  • [7] Lymphatic filariasis elimination endgame in an urban Indian setting: the roles of surveillance and residual microfilaremia after mass drug administration
    Anjali Modi
    Keshav G. Vaishnav
    Kailash Kothiya
    Neal Alexander
    [J]. Infectious Diseases of Poverty, 10
  • [8] Lymphatic filariasis elimination endgame in an urban Indian setting: the roles of surveillance and residual microfilaremia after mass drug administration
    Modi, Anjali
    Vaishnav, Keshav G.
    Kothiya, Kailash
    Alexander, Neal
    [J]. INFECTIOUS DISEASES OF POVERTY, 2021, 10 (01)
  • [9] Global Elimination of Lymphatic Filariasis: Addressing the Public Health Problem
    Addiss, David G.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (06)
  • [10] Elimination of lymphatic filariasis as a public health problem from Tonga
    Ofanoa, Reynold
    Ofa, Tukia
    Padmasiri, E. A.
    Kapa, D. Ramaiah
    [J]. TROPICAL MEDICINE AND HEALTH, 2019, 47 (1)